Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Innovation Pharmaceuticals Inc (IPIX) Message Board

I think the fact that the Virology Conference is v

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 72447
(Total Views: 759)
Posted On: 06/12/2021 11:09:16 PM
Posted By: petemantx
I think the fact that the Virology Conference is virtual plays heavily into IPIX's favor. I went over the Conference schedule and the GMU presentation is not listed in the top couple of levels of presentations which leads me to believe it would not have gotten that much attention at an in-person conference due to attendees being overwhelmed with what is considered more important presentations.

Being virtual, the attendees can listen to ALL the presentations over a longer period of time as they see fit. This should allow the GMU presentation to be listened to by most of the attendees IMO.

Many of the top level presentations are quite specific in addressing what IMO are very narrow areas of interest, whereas the GMU Brilacidin talk should be of interest to ALL attendees, being the introduction of a new arm of medicine and a specific drug that has yet to be defeated by any bacteria or virus. A broad spectrum wonder drug that has yet to meet any resistance to it. This is the goal of the conference, to make known the cutting edge of virology and that is spelled Brilacidin.

I think the GMU presentation will gob smack most of the virologists but I also believe they will be looking forward to it based on the earlier peer review that was sent out to them.

Whether the conference plays that heavily into IPIX's favor I have some doubts, but it should make Brilacidin a subject that all worldwide virologists will want to study further.

IPIX entered the CV19 fray for expanded Brilacidin broadcasting to the medical world, this conference should provide a major step in further accomplishing that goal.


(9)
(0)




Innovation Pharmaceuticals Inc (IPIX) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us